Systemic therapy for previously untreated advanced BRAF-mutated melanoma: navigating a shifting landscape
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- March 2017
has subject area
- 1103 Clinical Sciences (FoR)
- 1107 Immunology (FoR)
- 1115 Pharmacology and Pharmaceutical Sciences (FoR)
- Animals (MeSH)
- Antibodies, Monoclonal (MeSH)
- Antineoplastic Agents (MeSH)
- Clinical Trials as Topic (MeSH)
- Costimulatory and Inhibitory T-Cell Receptors (MeSH)
- Humans (MeSH)
- Immunotherapy (MeSH)
- MAP Kinase Kinase Kinases (MeSH)
- Melanoma (MeSH)
- Molecular Targeted Therapy (MeSH)
- Mutation (MeSH)
- Proto-Oncogene Proteins B-raf (MeSH)
- Pyridones (MeSH)
- Pyrimidinones (MeSH)
- Skin Neoplasms (MeSH)
published in
- Immunotherapy Journal